Mingquan H. Li
Changchun, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 41 publications
Comparison of the effects of different traditional Chinese exercises on improving the motor function of stroke survivors: a network meta-analysis and systematic review.
Journal: Frontiers in neurology
Published: February 26, 2026
Therapeutic potential of natural compounds from medicinal and food homology substances targeting gut microbiota in lipid metabolism disorders.
Journal: Frontiers in microbiology
Published: February 11, 2026
Puerarin as a Modulator of Synaptic Plasticity: Molecular Mechanisms Underlying Learning and Memory Restoration in Neurodegenerative Disorders.
Journal: Molecular neurobiology
Published: January 28, 2026
Global Research Trends of Protein Post-translational Modifications in Alzheimer's Disease: A Bibliometric Analysis.
Journal: Current neuropharmacology
Published: December 29, 2025
Type 2 Diabetes Reduces IFN-α2 and Compromises Antiviral Defense: Evidence From Mendelian Randomization and H1N1-Infected Diabetic Mice.
Journal: Diabetes
Published: October 29, 2025
Research progress on the regulation of Nrf2/HO-1 signaling pathway by traditional Chinese medicine in the treatment of Alzheimer's disease.
Journal: Journal of Alzheimer's disease : JAD
Published: October 22, 2025
Mechanisms and Pathogenesis of Diabetic Cognitive Impairment: A Comprehensive Review.
Journal: Aging and disease
Published: June 17, 2025
Insights into Biomarkers of Alzheimer's Disease: From Core Markers to Emerging Directions.
Journal: Aging and disease
Published: June 16, 2025
Natural Products from Chinese Medicine Targeting NF-κB Signaling: Emerging Therapeutic Avenues for Neurodegenerative Diseases.
Journal: Drug design, development and therapy
Published: April 16, 2025
Traditional Chinese Medicine Natural Products Targeting Shared Mechanisms of T2DM and AD: Potential Therapeutic Insights.
Journal: Drug design, development and therapy
Published: April 02, 2025
Puerarin as a dual inhibitor of Staphylococcus aureus coagulase and von Willebrand factor-binding protein for targeted therapy against MRSA skin infection.
Journal: Biochemical pharmacology
Published: March 28, 2025
Last Updated: 09/26/2026